Published on 17 Feb 2025
• Recently, Indian Immunologicals Ltd (IIL), a subsidiary of the National Dairy Development Board (NDDB) and a biopharmaceutical company from India, has launched India’s first indigenously developed Hepatitis A vaccine called ‘Havisure’.
• It is a two-dose vaccine: first dose administered at above 12 months of age and the second at least six months after the first dose.
• The vaccine is recommended for children as part of the routine immunization as well as for individuals at risk of exposure or travel to the regions with high hepatitis A prevalence.
• Hepatitis is liver inflammation caused by various factors, including viral infections, alcohol, medications, toxins, autoimmune diseases, and metabolic disorders. .
Havisure vaccine
Biotechnology
Hepatitis
Vaccine
PHARMACEUTICAL INDUSTRY